Biotech News
Decoy Therapeutics Joins Webull Corporate Connect Service Platform
investors.salariuspharma.com2026-05-06 15:23 EST
- Connect with the Company on Webull here CAMBRIDGE, Mass. and HOUSTON, Feb. 11, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, today announced that it